StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Lipella Pharmaceuticals's total assets was $2.35M at Sep 30, 2025. For fiscal 2024 it was $2.67M, down 25.3% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2024Dec 31, 2024$2.67M-25.3%
FY2023Dec 31, 2023$3.58M-39.9%
FY2022Dec 31, 2022$5.95M+195.6%
FY2021Dec 31, 2021$2.01M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$2.35M+8.8%
Q2 FY2025Jun 30, 2025$3.72M+70.3%
Q1 FY2025Mar 31, 2025$4.86M+54.8%
Q4 FY2024Dec 31, 2024$2.67M-25.3%
Q3 FY2024Sep 30, 2024$2.16M-24.0%
Q2 FY2024Jun 30, 2024$2.18M-37.4%
Q1 FY2024Mar 31, 2024$3.14M-32.0%
Q4 FY2023Dec 31, 2023$3.58M-39.9%
Q3 FY2023Sep 30, 2023$2.84M+41.1%
Q2 FY2023Jun 30, 2023$3.49M–
Q1 FY2023Mar 31, 2023$4.61M–
Q4 FY2022Dec 31, 2022$5.95M–
Q4 FY2021Dec 31, 2021$2.01M–

More Lipella Pharmaceuticals figures

See a number that looks wrong?